The HIV-1 Rev transactivator is phosphorylated in vitro by protein kinase C
K2 at two residues, Ser-5 and Ser-8; these sites are also phosphorylated in
vivo. Here we show that the mechanism by which CK2 phosphorylates Rev is u
nique in several respects, notably: (i) it is fully dependent on the regula
tory, beta-subunit of CK2; (ii) it relies on the integrity of an acidic str
etch of CE2 beta which down-regulates the phosphorylation of other substrat
es; (iii) it is inhibited in a dose-dependent manner by polyamines and othe
r polycationic effecters that normally stimulate CK2 activity, In contrast,
a peptide corresponding to the amino-terminal 26 amino acids of Rev, inclu
ding the phosphoacceptor site, is readily phosphorylated by the catalytic s
ubunit of CK2 even in the absence of the beta-subunit, These data, in conju
nction with the observation that two functionally inactive derivatives of R
ev with mutations in its helis-loop-helix motif are refractory to phosphory
lation, indicate the phosphorylation of Rev by CK2 relies on conformational
features of distinct regions that are also required for the transactivator
's biological activity. (C) 2000 Federation of European Biochemical Societi
es, Published by Elsevier Science B.V. All rights reserved.